MyFinsight
Home
Blog
About
Contact
Proceeds from
convertible notes, net
$1,500,000
Proceeds from share
purchases under eloc, net...
$456,166
Net cash provided by
financing activities
$1,956,166
Net (decrease)
increase in cash,...
-$804,891
Canceled cashflow
$1,956,166
Stock-based compensation
$1,617,455
Derivative expense
-$896,722
Prepaid expenses and
other current assets
-$354,991
Amortization of right-to-use
operating lease asset
$214,443
Accrued liabilities
$136,977
Amortization of debt discount
$136,765
Amortization of debt discount
$136,765
Accounts payable
$105,955
Depreciation expense
$61,699
Net cash used in
operating activities
-$2,761,057
Canceled cashflow
$3,661,772
Net loss
-$5,885,914
Operating lease liability
-$237,527
Insurance financing
liability
-$142,950
Gain on revaluation
of earnout...
-$19,500
Gain on revaluation
of earnout...
-$19,500
Foreign currency
transaction gain included in...
$173
Net loss
-$5,885,914
Back
Back
Cash Flow
CERO THERAPEUTICS HOLDINGS, INC. (CEROW)
CERO THERAPEUTICS HOLDINGS, INC. (CEROW)
source: myfinsight.com